评估Roxadustat在经过腹膜透析的患者中对心室再极化的影响
Yangyang Zhang1, Liang Zhang2, Pengcheng Ge1
1Department of Cardiology, Suqian First Hospital, Suqian, Jiangsu, China.
European journal of medical research
|October 11, 2023
概括
在腹膜透析患者中,Roxadustat治疗改善了心室再极化,显示出潜在的心血管益处. 这一发现表明,Roxadustat可能为治疗慢性病并发症提供了一种新方法.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 罗沙杜沙特是治疗慢性病 (CKD) 患者贫血的口服药物.
- 研究表明,Roxadustat可以改善血红蛋白和铁代谢.
- 这项研究评估了Roxadustat对腹膜透析 (PD) 患者腹腔室再极化的影响.
研究的目的:
- 评估Roxadustat对心室再极化在PD患者的影响.
- 为了探索Roxadustat的潜在心血管保护作用.
- 研究一种用于CKD评估和治疗的新方法.
主要方法:
- 65名接受Roxadustat治疗的CKD患者和31名接受常规治疗的前性队列研究 (2021年1月至2022年6月).
- 电心电图 (ECG) 的指标进行了比较,包括T峰至终 (Tpe) 和Tpe/QT比率.
- 人口和临床数据采集并使用SPSS 18.0.0.进行分析.
主要成果:
- 与常规治疗组相比,Roxadustat组的T峰至终 (Tpe) 间隔显著较慢.
- 在传统组与Roxadustat组相比,Tpe/QT比率显著增加.
- 后勤回归确定了Tpe和Roxadustat治疗作为PD患者高Tpe/QT比率的风险因素.
结论:
- 罗沙杜沙特改善了PD患者的腹腔再极化,这表明了潜在的心血管保护作用.
- 这一发现可能为评估和治疗CKD提供一种新的综合方法.
- 对Roxadustat在CKD患者的心血管益处进行进一步研究是有必要的.
相关概念视频
Peritoneal Dialysis I: Introduction and Procedure
41
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
41
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
26
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
26
Peritoneal Dialysis III: Nursing Management
31
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
31
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
854
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
854
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K


